Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis

被引：2

作者：

Boyd, MA ^{[1
]}

Burger, DM

Phanuphak, P

Cooper, DA

机构：

[1] Flinders Univ S Australia, Dept Microbiol & Infect Dis, Bedford Pk, SA 5042, Australia

[2] Radboud Univ, Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands

[3] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand

[4] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia

来源：

AIDS | 2006年 / 20卷 / 07期

关键词：

D O I：

10.1097/01.aids.0000222090.52035.b2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1083 / 1085

页数：3

共 13 条

[1] RESPONSE TO TREATMENT, MORTALITY, AND CD4 LYMPHOCYTE COUNTS IN HIV-INFECTED PERSONS WITH TUBERCULOSIS IN ABIDJAN, COTE-DIVOIRE [J].

ACKAH, AN ;

COULIBALY, D ;

DIGBEU, H ;

DIALLO, K ;

VETTER, KM ;

COULIBALY, IM ;

GREENBERG, AE ;

DECOCK, KM .

LANCET, 1995, 345 (8950) :607-610

[2]

[Anonymous], MMWR

[3]

[Anonymous], 2004, SCAL ANT THER RES LT

[4]

Boyd M, 2005, ANTIVIR THER, V10, P301

[5] Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir 400 mg indinavir in HIV-infected patients [J].

Ghosn, J ;

Lamotte, C ;

Ait-Mohand, H ;

Wirden, M ;

Agher, R ;

Schneider, L ;

Bricaire, F ;

Duvivier, C ;

Calvez, V ;

Peytavin, G ;

Katlama, C .

AIDS, 2003, 17 (02) :209-214

[6] Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients [J].

Justesen, US ;

Andersen, ÅB ;

Klitgaard, NA ;

Brosen, K ;

Gerstoft, J ;

Pedersen, C .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :426-429

[7] Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin [J].

Manosuthi, W ;

Sungkanuparph, S ;

Thakkinstian, A ;

Vibhagool, A ;

Kiertiburanakul, S ;

Rattanasiri, S ;

Prasithsirikul, W ;

Sankote, J ;

Mahanontharit, A ;

Ruxrungtham, K .

AIDS, 2005, 19 (14) :1481-1486

[8]

Mootsikapun P, 2005, ANTIVIR THER, V10, P911

[9]

*PAN CLIN PRACT TR, GUID US ANT AG HIV I

[10]

POZNIAK AL, BHIVA TREATMENT GUID

← 1 2 →